CH546788A - PROCESS FOR PREPARING ANTI-INFLAMMATORY AGENTS. - Google Patents

PROCESS FOR PREPARING ANTI-INFLAMMATORY AGENTS.

Info

Publication number
CH546788A
CH546788A CH961272A CH546788DA CH546788A CH 546788 A CH546788 A CH 546788A CH 961272 A CH961272 A CH 961272A CH 546788D A CH546788D A CH 546788DA CH 546788 A CH546788 A CH 546788A
Authority
CH
Switzerland
Prior art keywords
inflammatory agents
preparing anti
preparing
inflammatory
agents
Prior art date
Application number
CH961272A
Other languages
French (fr)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH546788A publication Critical patent/CH546788A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH961272A 1971-06-28 1972-06-27 PROCESS FOR PREPARING ANTI-INFLAMMATORY AGENTS. CH546788A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15767871A 1971-06-28 1971-06-28
CA143149 1972-05-26

Publications (1)

Publication Number Publication Date
CH546788A true CH546788A (en) 1974-03-15

Family

ID=25667058

Family Applications (1)

Application Number Title Priority Date Filing Date
CH961272A CH546788A (en) 1971-06-28 1972-06-27 PROCESS FOR PREPARING ANTI-INFLAMMATORY AGENTS.

Country Status (5)

Country Link
US (1) US3767653A (en)
CH (1) CH546788A (en)
DE (1) DE2230592A1 (en)
FR (1) FR2147960B1 (en)
GB (1) GB1388054A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4006161A (en) * 1973-12-26 1977-02-01 Eli Lilly And Company Thio-substituted 2-oxo-indolines
JPS5121827A (en) * 1974-08-14 1976-02-21 Fuji Photo Film Co Ltd Shashinyokapuraa
US4268301A (en) * 1978-04-17 1981-05-19 Sumitomo Chemical Company, Limited 1,4-Benzothiazines
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (en) * 1984-03-19 1990-10-25 Pfizer METHOD FOR PRODUCING 2-OXINDOLE-1-CARBOXAMIDES AND THEIR INTERMEDIATE PRODUCTS.
US4808601A (en) * 1984-09-19 1989-02-28 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
DE3545097A1 (en) * 1985-12-19 1987-07-02 Bayer Ag 1-H-PYRIDO- (3,2-B) (1,4) THIAZINE
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
WO2017196970A1 (en) 2016-05-10 2017-11-16 Georgia State University Research Foundation, Inc. Heterocyclic derivatives for the thratment of rsv
CN109562160B (en) 2016-05-10 2022-07-29 乔治亚州立大学研究基金会股份有限公司 Bicyclic fused pyrazole derivatives for the treatment of RSV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471481A (en) * 1966-03-28 1969-10-07 Squibb & Sons Inc Benzothiazines

Also Published As

Publication number Publication date
GB1388054A (en) 1975-03-19
FR2147960B1 (en) 1976-03-05
DE2230592A1 (en) 1973-01-11
US3767653A (en) 1973-10-23
FR2147960A1 (en) 1973-03-11

Similar Documents

Publication Publication Date Title
BE763529A (en) PROCESS FOR PREPARING ALLOPHANATE-POLYISOCYANATES
CH552610A (en) AZAPURINONES PREPARATION PROCESS.
BE768485A (en) PROCESS FOR PREPARING ARYLOXY-1,1,2,2-TETRAFLUORO-ETHANES
BE784222A (en) PROCESS FOR PREPARING HOP EXTRACTS
CH555316A (en) PROCESS FOR PREPARING AMINOCYCLOALCENYLO-CYCLOHEXENOLS.
CH546788A (en) PROCESS FOR PREPARING ANTI-INFLAMMATORY AGENTS.
CH551371A (en) PROCESS FOR PREPARING AMINO-ALCANOL COMPOUNDS.
CH554319A (en) PROCESS FOR THE PREPARATION OF ORTHO-DISUBSTITUTED ARYL-GUANIDINES.
BE786840A (en) PROCESS FOR PREPARING 1,2,4-TRIAZINE -5-ONES
BE786518A (en) OXA-BICYCLO-ALCENES PREPARATION PROCESS
BE785344A (en) PROCESS FOR THE PREPARATION OF ALCENYL-SILANES
CH550187A (en) PROCESS FOR THE PREPARATION OF EBURNAMONINE.
BE777068A (en) PROCESS FOR PREPARING ALCOYLPHENOLS
BE788171A (en) METHOD FOR PREPARING ALCOYL-TETRALINES
BE761304A (en) PROCESS FOR PREPARING AMINOPHENYL-TRIAL-COXY-SILANES
BE777067A (en) PROCESS FOR PREPARING ALCOYLPHENOLS
BE804528A (en) PROCESS FOR PREPARING ALMYL TRANS-CHRYSANTHEMATES
BE790056A (en) PROCESS FOR THE PREPARATION OF 1, 1'-DIANTHRAQUINONYLES
CH550195A (en) PROCESS FOR THE PREPARATION OF DERIVATIVES OF ISOXAZOLOPYRIDINECETONES.
BE803370A (en) PROCESS FOR PREPARING AMINO-ANTHRAQUINONES
BE799198A (en) PROCESS FOR PREPARING AMINDAZETIDINONES,
BE781275A (en) PROCESS FOR THE PREPARATION OF O-AMINOBENZONITRILS
BE783223A (en) PROCESS FOR PREPARING ANTIBACTERIAL AGENTS
BE804619A (en) PROCESS FOR PREPARING HALOPHENOXYNITROBENZOATES
BE767309A (en) PROCESS FOR PREPARING LOWER ALCOYL FLAVONE-7-OXYACETATES

Legal Events

Date Code Title Description
PL Patent ceased